Table 3 Multivariate multilevel analysis of PMTCT performance by site-, program- and contextual-level predictors: nevirapine coverage ratio (NCR)
β Coefficient | p-value | (95% CI) | ||
|---|---|---|---|---|
Site characteristics | ||||
Activity (antenatal care) | ||||
< 30 / month | 0 (ref) | - | ||
30 - 100 / month | -7.6 | 0.05 | (-15.1 ; -0.06) | |
>100 / month | -2.3 | 0.59 | (-10.7 ; 6.1) | |
Country-level characteristics | ||||
Prevalence of HIV (% of population ages 15–49) | ||||
<Median (1.2-5.4) | 0 (ref) | - | ||
>Median (6.4-23.4) | 25.1 | <10-4 | (18.7 ; 31.6) | |
% With knowledge about PMTCT | ||||
<Median (2.7-33.1) | 0 (ref) | - | ||
>Median (33.3-66.2) | 8.3 | 0.04 | (0.53 ; 16.0) | |
Health expenditure (% of GDP*) | 3.9 | <10-4 | (2.0 ; 5.8) | |
Rural population (% of total population) | -0.74 | <10-4 | (-1.0 ; -0.46) | |